JP2008525513A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525513A5 JP2008525513A5 JP2007548747A JP2007548747A JP2008525513A5 JP 2008525513 A5 JP2008525513 A5 JP 2008525513A5 JP 2007548747 A JP2007548747 A JP 2007548747A JP 2007548747 A JP2007548747 A JP 2007548747A JP 2008525513 A5 JP2008525513 A5 JP 2008525513A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- compound
- formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04380279A EP1676844A1 (en) | 2004-12-28 | 2004-12-28 | 5-HT7 receptor antagonists |
| US11/048,992 US7345057B2 (en) | 2004-12-28 | 2005-02-02 | 5-HT7 receptor antagonists |
| PCT/EP2005/014046 WO2006069776A1 (en) | 2004-12-28 | 2005-12-27 | 5-ht7 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008525513A JP2008525513A (ja) | 2008-07-17 |
| JP2008525513A5 true JP2008525513A5 (OSRAM) | 2009-02-12 |
Family
ID=34931894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548747A Pending JP2008525513A (ja) | 2004-12-28 | 2005-12-27 | ５−ｈｔ７受容体拮抗薬 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7345057B2 (OSRAM) |
| EP (2) | EP1676844A1 (OSRAM) |
| JP (1) | JP2008525513A (OSRAM) |
| KR (1) | KR20070091040A (OSRAM) |
| CN (1) | CN101090898A (OSRAM) |
| AU (1) | AU2005321463A1 (OSRAM) |
| BR (1) | BRPI0519792A2 (OSRAM) |
| CA (1) | CA2590666A1 (OSRAM) |
| MX (1) | MX2007007894A (OSRAM) |
| RU (1) | RU2007128926A (OSRAM) |
| WO (1) | WO2006069776A1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103880827B (zh) | 2004-07-15 | 2017-01-04 | 阿尔巴尼分子研究公司 | 芳基和杂芳基取代的四氢异喹啉及其阻断去甲肾上腺素、多巴胺和血清素的重摄取的应用 |
| US8507523B2 (en) * | 2006-11-21 | 2013-08-13 | Renukadevi Patil | Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy |
| US8202873B2 (en) * | 2007-05-11 | 2012-06-19 | Eli Lilly And Company | 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| WO2010080864A1 (en) | 2009-01-12 | 2010-07-15 | Array Biopharma Inc. | Piperidine-containing compounds and use thereof |
| KR101830447B1 (ko) * | 2009-05-12 | 2018-02-20 | 알바니 몰레큘라 리써치, 인크. | 7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도 |
| US8815894B2 (en) * | 2009-05-12 | 2014-08-26 | Bristol-Myers Squibb Company | Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
| EP2429295B1 (en) | 2009-05-12 | 2013-12-25 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
| EA029430B1 (ru) * | 2013-06-21 | 2018-03-30 | Такеда Фармасьютикл Компани Лимитед | Производные 1-сульфонилпиперидина в качестве модуляторов рецепторов прокинетицина |
| GB201420095D0 (en) | 2014-11-12 | 2014-12-24 | Takeda Pharmaceutical | New use |
| EP3589626B1 (en) * | 2017-03-03 | 2024-06-12 | National Taiwan University | 8-phenyl-isoquinolines and pharmaceutical composition thereof used in the treatment of irritable bowel syndrome |
| US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
| CN112083107B (zh) * | 2020-09-28 | 2022-07-05 | 中国计量科学研究院 | 检测蜂蜜基质中磺胺类药物葡萄糖醛酸结合物的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ193654A (en) | 1979-05-16 | 1984-08-24 | Wuelfing Johann A | Naphthalene sulphonamido-alkyl-piperidines,pyrrolidines or piperazines and pharmaceutical compositions |
| EP0076072B1 (en) | 1981-09-24 | 1987-05-13 | BEECHAM - WUELFING GmbH & Co. KG | Sulphonamides |
| WO1997029097A1 (en) | 1996-02-09 | 1997-08-14 | Smithkline Beecham Plc | Sulfonamide derivatives as 5ht7 receptor antagonists |
| GB9612884D0 (en) | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| WO1997049695A1 (en) * | 1996-06-25 | 1997-12-31 | Smithkline Beecham P.L.C. | Sulfonamide derivatives as 5ht7 receptor antagonists |
| WO1999024022A2 (en) | 1997-11-10 | 1999-05-20 | F. Hoffmann-La Roche Ag | Isoquinoline derivatives for treating disorders associated with 5ht7 receptors |
| AU4698299A (en) * | 1998-06-30 | 2000-01-17 | Du Pont Pharmaceuticals Company | 5-HT7 receptor antagonists |
| GB0128885D0 (en) | 2001-12-03 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
-
2004
- 2004-12-28 EP EP04380279A patent/EP1676844A1/en not_active Withdrawn
-
2005
- 2005-02-02 US US11/048,992 patent/US7345057B2/en not_active Expired - Fee Related
- 2005-12-27 KR KR1020077017187A patent/KR20070091040A/ko not_active Withdrawn
- 2005-12-27 WO PCT/EP2005/014046 patent/WO2006069776A1/en not_active Ceased
- 2005-12-27 CN CNA2005800452243A patent/CN101090898A/zh active Pending
- 2005-12-27 JP JP2007548747A patent/JP2008525513A/ja active Pending
- 2005-12-27 CA CA002590666A patent/CA2590666A1/en not_active Abandoned
- 2005-12-27 BR BRPI0519792-9A patent/BRPI0519792A2/pt not_active IP Right Cessation
- 2005-12-27 AU AU2005321463A patent/AU2005321463A1/en not_active Abandoned
- 2005-12-27 EP EP05849072A patent/EP1831195B1/en not_active Expired - Lifetime
- 2005-12-27 MX MX2007007894A patent/MX2007007894A/es not_active Application Discontinuation
- 2005-12-27 RU RU2007128926/04A patent/RU2007128926A/ru not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008525513A5 (OSRAM) | ||
| JP2010520869A5 (OSRAM) | ||
| JP2008133297A5 (OSRAM) | ||
| WO2010129467A1 (en) | Compounds and methods for inhibition of renin, and indications therefor | |
| KR20060027338A (ko) | 벤즈 아미드 유도체 또는 그 염 | |
| JPWO2012102254A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| JP2009538358A (ja) | 脂肪酸アミド加水分解酵素のオキサゾリルピペリジン・モジュレーター | |
| JP2008505107A5 (OSRAM) | ||
| JP2015178458A (ja) | ベンゼン環縮合含窒素５員複素環式化合物、またはその薬理学的に許容される塩 | |
| JP2007015928A (ja) | 新規オレフィン誘導体 | |
| CA2570197A1 (en) | Nk1 antagonists | |
| RU2582337C2 (ru) | Производные триазола в качестве лигандов рецепторов гамк | |
| JP2010504351A5 (OSRAM) | ||
| US7671056B2 (en) | Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor | |
| JP2004507527A5 (OSRAM) | ||
| WO2011013624A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| JP2007530648A (ja) | Ｃｎｓ障害の処置のための、５−ｈｔ６受容体アンタゴニストとしての３−（（ヘテロ）アリールスルフォニル）−８−（（アミノアルキル）オキシ）キノリン | |
| JP6943239B2 (ja) | Ｋｃｎｑ２〜５チャネル活性化剤 | |
| JP2005528367A5 (OSRAM) | ||
| JP2008525512A5 (OSRAM) | ||
| CA2720461C (en) | Classes of gabaa/bzr ligands | |
| JP3887785B2 (ja) | ５−ｈｔ２レセプター親和性を有する置換四環状オキサゼピン及びチアゼピン誘導体 | |
| JPWO2006132438A1 (ja) | １，３−ベンゾチアジノン誘導体およびその用途 | |
| JP2006523223A5 (OSRAM) | ||
| JP4042566B2 (ja) | ピペリジン化合物およびその医薬用途 |